Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia?

Immunohematology

Volumn 21, Issue 3, 2005, Pages 102-108

  Bessos, Hagop ^a   Turner, Marc L ^a,b   Urbaniak, Stanislaw J ^a,c  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti HPA 1a; Neonatal alloimmune thrombocytopenia (NAIT); Platelets

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; HPA 1A ANTIBODY; HPA 1A ANTIGEN; IMMOBILIZED ANTIBODY; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; HOMOZYGOSITY; HUMAN; NEWBORN ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 25844459024     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
2. Blanchette VS, Chen I, de Friedberg ZS, et al. Alloimmunization to the PLA1 platelet antigen: results of a prospective study. Br J Haematol 1990;74:209-15.
3. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6.
4. Bussel J, Kaplan C. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. Baillieres Clin Haematol 1998;11:391-408.
5. Voak D, Mitchell R, Bowell P, et al. Guidelines for blood grouping and red cell antibody testing during pregnancy. Transfus Med 1996;6:71-4.
6. von dem Borne AE, van Leeuwen EF, von Riesz LE, et al. Neonatal alloimmune thrombocytopenia: detection and characterization of the responsible antibodies by the platelet immunoflourescence test. Blood 1981;57:649-56.
7. McFarland JG, Frenzke M, Aster RH. Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia. Transfusion 1988; 29:128-33.
8. Kaplan C, Daffos F, Forestier F, et al. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988;72:340-3.
9. Bussel JB, Berkowitz RL, McFarland JG, et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Eng J Med 1988;319:1374-8.
10. Proulx C, Filion M, Goldman M, et al. Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia. Br J Haematol 1994;87:813-7.
11. Panzer S, Auerbach L, Cechova E, et al. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol 1995;90:655-60.
12. Durand-Zaleski I, Schlegel N, Blum Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comaprison of effectiveness and costs. Am J Perinatol 1996;13:423-31.
13. Mawas F, Wiener E, Williamson LM, et al. Immunogolobulin G subclass of anti-human platelet antigen 1a in maternal sera: relation to the severity of neonatal alloimmune thrombocytopenia. Br J Haematol 1997;59:287-92.
14. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet specific antigen HPA-1a (PLA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.
15. Jaegtvik S, Husebekk A, Aune B, et al. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000;107:691-4.
16. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody, and alloimmune thrombocytopenia. Vox Sang 2003;85:326-7.
17. Turner M, Bessos H, Fagge T, et al. Prospective epidemiological study of the outcome and cost effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-1a.Transfusion. In Press.
18. Bessos H, Goldschmeding R, von dem Borne A, et al. The development of a simple and quick enzyme-linked immunosorbent assay for anti-HPA-1a (PLA1) antibodies. Thromb Res 1993;69:395-400.
19. Porcelijn L, von dem Borne AE. Immune-mediated thrombocytopenias: basic and immunological aspects. Baillieres Clin Haematol 1998:331-41.
20. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
21. Bessos H, Perez S, Armstrong-Fisher S, et al. The development of a quantitative ELISA for antibodies against human platelet antigen type 1a. Transfusion 2003;43:350-6.
22. Bessos H, Hofner M, Salamat A, et al. An international trial demonstrates suitability of a newly developed whole-blood ELISA kit for multicentre platelet HPA-1 phenotyping. Vox Sang 1999;77:103-6.
23. Sukati H, Bessos H, Barker RN, Urbaniak SJ. Characterization of the alloreactive helper T-cell response to the platelet membrane glycprotein IIIa (integrin beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005;45:1165-77.
24. Kurz M, Stockelle E, Eichelberger B, Panzer S. IgG titer, subclass, and light chain phenotype of pregnancy-induced HPA-5b antibodies that cause or do not cause neonatal alloimmune thrombocytopenia. Transfusion 1999;39:379-82.
25. Ohio H, Yamaguchi T, Takeuchi C, et al. Anti-HPA-5b-induced neonatal alloimmune thrombocytopenia: antibody titre as a predictor. Br J Haematol 2000;110:223-7.
26. Ohio H, Miura S, Ariga H, et al. The natural history of maternal immunization against fetal platelet alloantigens. Transfus Med 2004;14:399-408.
27. Birchall JE, Murphy MF, Kaplan C, et al. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003;122:275-88.